Insider Transactions in Q4 2025 at Natera, Inc. (NTRA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
1,500
-1.62%
|
$337,500
$225.58 P/Share
|
|
Dec 17
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-0.45%
|
$696,890
$227.42 P/Share
|
|
Dec 15
2025
|
Jonathan Sheena |
SELL
Bona fide gift
|
Direct |
1,060
-0.47%
|
-
|
|
Dec 15
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Bona fide gift
|
Direct |
115
-0.09%
|
-
|
|
Dec 12
2025
|
Herm Rosenman |
SELL
Open market or private sale
|
Direct |
48,419
-24.71%
|
$10,991,113
$227.89 P/Share
|
|
Dec 12
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
BUY
Exercise of conversion of derivative security
|
Direct |
22,376
+8.32%
|
$201,384
$9.59 P/Share
|
|
Dec 12
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
4,692
-3.98%
|
$1,079,160
$230.76 P/Share
|
|
Dec 12
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Bona fide gift
|
Direct |
180
-0.17%
|
-
|
|
Dec 09
2025
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
4,436
+1.92%
|
$39,924
$9.29 P/Share
|
|
Dec 05
2025
|
Rowan E Chapman |
SELL
Open market or private sale
|
Direct |
4,366
-22.7%
|
$1,060,938
$243.24 P/Share
|
|
Dec 05
2025
|
Rowan E Chapman |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+28.28%
|
$128,000
$32.15 P/Share
|
|
Dec 04
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,902
+3.2%
|
$131,138
$19.68 P/Share
|
|
Dec 01
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
4,400
-1.02%
|
$1,047,200
$238.21 P/Share
|
|
Dec 01
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.68%
|
$714,000
$238.19 P/Share
|
|
Nov 24
2025
|
Roelof Botha Director |
SELL
Open market or private sale
|
Indirect |
75,000
-0.57%
|
$17,550,000
$234.43 P/Share
|
|
Nov 21
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
4,000
-7.91%
|
$920,000
$230.01 P/Share
|
|
Nov 20
2025
|
Roy D. Baynes |
SELL
Open market or private sale
|
Direct |
7,668
-6.72%
|
$1,702,296
$222.73 P/Share
|
|
Nov 20
2025
|
Roy D. Baynes |
BUY
Exercise of conversion of derivative security
|
Direct |
7,668
+12.21%
|
$314,388
$41.06 P/Share
|
|
Nov 20
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
10,000
-4.3%
|
$2,250,000
$225.08 P/Share
|
|
Nov 19
2025
|
Roy D. Baynes |
SELL
Open market or private sale
|
Direct |
5,112
-7.84%
|
$1,093,968
$214.78 P/Share
|
|
Nov 19
2025
|
Roy D. Baynes |
BUY
Exercise of conversion of derivative security
|
Direct |
5,112
+17.88%
|
$204,480
$40.93 P/Share
|
|
Nov 11
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
1,500
-0.97%
|
$312,000
$208.03 P/Share
|
|
Nov 07
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-0.19%
|
$595,580
$194.12 P/Share
|
|
Nov 04
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
22,900
-0.5%
|
$4,580,000
$200.73 P/Share
|
|
Nov 03
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.88%
|
$594,000
$198.96 P/Share
|
|
Nov 03
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
4,000
-7.13%
|
$800,000
$200.07 P/Share
|
|
Nov 03
2025
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
122
-2.07%
|
$24,156
$198.71 P/Share
|
|
Nov 03
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
160,703
-17.77%
|
$31,819,194
$199.0 P/Share
|
|
Nov 03
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
155,679
+12.18%
|
$7,939,629
$51.01 P/Share
|
|
Nov 03
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
17,100
-0.74%
|
$3,420,000
$200.0 P/Share
|
|
Oct 31
2025
|
Herm Rosenman |
BUY
Grant, award, or other acquisition
|
Direct |
132
+0.19%
|
-
|
|
Oct 31
2025
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
93
+0.5%
|
-
|
|
Oct 31
2025
|
Monica Bertagnolli |
BUY
Grant, award, or other acquisition
|
Direct |
93
+1.75%
|
-
|
|
Oct 31
2025
|
Roelof Botha Director |
BUY
Grant, award, or other acquisition
|
Direct |
149
+2.13%
|
-
|
|
Oct 31
2025
|
Rowan E Chapman |
BUY
Grant, award, or other acquisition
|
Direct |
128
+2.04%
|
-
|
|
Oct 31
2025
|
Gail Boxer Marcus |
BUY
Grant, award, or other acquisition
|
Direct |
121
+2.02%
|
-
|
|
Oct 31
2025
|
Brinkley Ruth Williams |
BUY
Grant, award, or other acquisition
|
Direct |
97
+1.79%
|
-
|
|
Oct 29
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,867
-0.71%
|
$354,730
$190.35 P/Share
|
|
Oct 28
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,415
-0.89%
|
$461,265
$191.26 P/Share
|
|
Oct 28
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
3,680
-2.4%
|
$702,880
$191.46 P/Share
|
|
Oct 28
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
928
-0.61%
|
$177,248
$191.46 P/Share
|
|
Oct 28
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
1,198
-1.03%
|
$228,818
$191.46 P/Share
|
|
Oct 28
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,058
-0.52%
|
$202,078
$191.46 P/Share
|
|
Oct 28
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
191
-0.08%
|
$36,481
$191.46 P/Share
|
|
Oct 27
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
781
-1.13%
|
$149,952
$192.32 P/Share
|
|
Oct 27
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
2,335
-1.5%
|
$448,320
$192.32 P/Share
|
|
Oct 27
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
781
-0.51%
|
$149,952
$192.32 P/Share
|
|
Oct 27
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
1,008
-0.86%
|
$193,536
$192.32 P/Share
|
|
Oct 27
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
935
-0.46%
|
$179,520
$192.32 P/Share
|
|
Oct 27
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
288
-0.12%
|
$55,296
$192.32 P/Share
|